Commentary

Is “Return of the Dotcom Bust” coming to a business theater near you? Columnist Brad Spirrison thinks the $15 billion valuation for Facebook could be a prelude to a second "dot-comedy," and he quotes several venture capitalists that view this level of valuation as an...

Unless you regularly are involved in venture capital transactions and stay up to date on recent trends and deal structures, it's hard to know if you're taking advantage of best industry practices. Attorney and columnist Matt Storms has a handy resource, the American Bar Association's...

Is there a control mechanism that allows computer programmers into production while still providing some assurance that they are not accidentally jeopardizing (or intentionally manipulating) software? You bet there is, and Jerry Norton explains it in this edition of Boardroom Perspectives. According to Norton, the...

The non-statutory stock option, typically afforded executives in companies, has been the subject of the recent backdating scandals faced by a number of high-profile tech companies, noted legal columnist Sverre Roang. In this WTN Guest Column, Roang delves deeper into the “NSO” and explains why...

Could financial industry CIOs have better used IT to mitigate subprime exposure? The answer is yes, says columnist Patrick Gray, if the CIOs had expanded their definition of business intelligence. In this edition of Breakthrough IT, he states that simply building data repositories is not...

During the 1990s, the rush by Big Pharma to enhance patient compliance involved going from regular dosage release to controlled release. According to columnist Michael Rosen, this mechanism allowed for better patient compliance and also afforded some additional patent protection and product life. In this...

The world of angel investing can teach many business lessons, primarily about the importance of management in overcoming the seemingly insurmountable odds of early-stage ventures, according to columnist and software executive Geoff Bastow. In this edition of Leading IT, Bastow recounts the 10 commandments of...

For those who wonder if all this new scientific collaboration is really beneficial, the recent stem cell discovery should provide ample proof, according to columnist Tom Still. In this edition of Inside Wisconsin, Still notes that collaboration has born fruit with NimbleGen's laboratory and production...

The recent discovery by scientists in Wisconsin and Japan not only resolves ethical issues associated with embryonic stem cell research, it will lead to more practical and effective stem cell research, according to the executive director of Wisconsin Right to Life. In this guest column...